Start date: 01/05/2017
End date: 30/04/2023
Project Code: A4166_5440
Acronym: TRANSVAC2
TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines
